Cytochrome P450 3A43
Details
- Name
- Cytochrome P450 3A43
- Synonyms
- 1.14.14.1
- Gene Name
- CYP3A43
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0006840|Cytochrome P450 3A43 MDLIPNFAMETWVLVATSLVLLYIYGTHSHKLFKKLGIPGPTPLPFLGTILFYLRGLWNF DRECNEKYGEMWGLYEGQQPMLVIMDPDMIKTVLVKECYSVFTNQMPLGPMGFLKSALSF AEDEEWKRIRTLLSPAFTSVKFKEMVPIISQCGDMLVRSLRQEAENSKSINLKDFFGAYT MDVITGTLFGVNLDSLNNPQDPFLKNMKKLLKLDFLDPFLLLISLFPFLTPVFEALNIGL FPKDVTHFLKNSIERMKESRLKDKQKHRVDFFQQMIDSQNSKETKSHKALSDLELVAQSI IIIFAAYDTTSTTLPFIMYELATHPDVQQKLQEEIDAVLPNKAPVTYDALVQMEYLDMVV NETLRLFPVVSRVTRVCKKDIEINGVFIPKGLAVMVPIYALHHDPKYWTEPEKFCPERFS KKNKDSIDLYRYIPFGAGPRNCIGMRFALTNIKLAVIRALQNFSFKPCKETQIPLKLDNL PILQPEKPIVLKVHLRDGITSGP
- Number of residues
- 503
- Molecular Weight
- 57669.21
- Theoretical pI
- 8.25
- GO Classification
- Functionsaromatase activity / heme binding / iron ion binding / monooxygenase activityProcessessmall molecule metabolic process / xenobiotic metabolic processComponentsendoplasmic reticulum membrane
- General Function
- Monooxygenase activity
- Specific Function
- Exhibits low testosterone 6-beta-hydroxylase activity.
- Pfam Domain Function
- p450 (PF00067)
- Transmembrane Regions
- Not Available
- Cellular Location
- Endoplasmic reticulum membrane
- Gene sequence
>lcl|BSEQ0012469|Cytochrome P450 3A43 (CYP3A43) ATGGATCTCATTCCAAACTTTGCCATGGAAACATGGGTTCTTGTGGCTACCAGCCTGGTA CTCCTCTATATTTATGGGACCCATTCACATAAACTTTTTAAGAAGCTGGGAATTCCTGGG CCAACCCCTCTGCCTTTTCTGGGAACTATTTTGTTCTACCTTAGGAGGTCTCTGAATAAG ATTCCCAGCTGGGCGTGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAAGCA GGAGGATCACCTAAGGTCAGGAGTTCGAGACCAGCTTTGCCAACATGGGTCTTTGGAATT TTGACAGAGAATGTAATGAAAAATACGGAGAAATGTGGGGCACTCTTTCCATTTCTTACC CCAGTTTTTGAAGCCCTAAATATCGGTTTGTTTCCAAAAGATGTTACCCATTTTTTAAAA AATTCCATTGAAAGGATGAAAGAAAGTCGCCTCAAAGATAAACAAAAGCATCGAGTAGAT TTCTTTCAACAGATGATCGACTCCCAGAATTCCAAAGAAACAAAGTCCCATAAAGCTCTG TCTGATCTGGAGCTTGTGGCCCAGTCAATTATCATCATTTTTGCTGCCTATGACACAACT AGCACCACTCTCCCCTTCATTATGTATGAACTGGCCACTCACCCTGATGTCCAGCAGAAA CTGCAGGAGGAGATTGACGCAGTTTTACCCAATAAGGCACCTGTCACCTACGATGCCCTG GTACAGATGGAGTACCTTGACATGGTGGTGAATGAAACGCTCAGATTATTCCCAGTTGTT AGTAGAGTTACGAGAGTCTGCAAGAAAGATATTGAAATCAATGGAGTGTTCATTCCCAAA GGGTTAGCAGTGATGGTTCCAATCTATGCTCTTCACCATGACCCAAAGTACTGGACAGAG CCTGAGAAGTTCTGCCCTGAAAGGTTCAGTAAGAAGAACAAGGACAGCATAGATCTTTAC AGATACATACCTTTTGGAGCTGGACCCCGAAACTGCATTGGCATGAGGTTTGCTCTCACA AACATAAAACTTGCTGTCATTAGAGCACTGCAGAACTTCTCCTTCAAACCTTGTAAAGAG ACTCAGATCCCACTGAAATTAGACAATCTACCAATTCTTCAACCAGAAAAACCTATTGTT CTAAAAGTGCACTTAAGAGATGGGATTACAAGTGGACCCTGA
- Chromosome Location
- 7
- Locus
- 7q21.1
- External Identifiers
Resource Link UniProtKB ID Q9HB55 UniProtKB Entry Name CP343_HUMAN GenBank Protein ID 12642642 GenBank Gene ID AF319634 HGNC ID HGNC:17450 - General References
- Domanski TL, Finta C, Halpert JR, Zaphiropoulos PG: cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol. 2001 Feb;59(2):386-92. [Article]
- Westlind A, Malmebo S, Johansson I, Otter C, Andersson TB, Ingelman-Sundberg M, Oscarson M: Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochem Biophys Res Commun. 2001 Mar;281(5):1349-55. [Article]
- Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, Bishop C, Koebe HG, Brinkmann U, Klenk HP, Kleine K, Meyer UA, Wojnowski L: Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics. 2001 Mar;11(2):111-21. [Article]
- Cauffiez C, Lo-Guidice JM, Chevalier D, Allorge D, Hamdan R, Lhermitte M, Lafitte JJ, Colombel JF, Libersa C, Broly F: First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant. Hum Mutat. 2004 Jan;23(1):101. [Article]
- Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64. [Article]
- Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7. [Article]
- Finta C, Zaphiropoulos PG: Intergenic mRNA molecules resulting from trans-splicing. J Biol Chem. 2002 Feb 22;277(8):5882-90. Epub 2001 Nov 28. [Article]
- Hillman RT, Green RE, Brenner SE: An unappreciated role for RNA surveillance. Genome Biol. 2004;5(2):R8. Epub 2004 Feb 2. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB13179 Troleandomycin approved unknown inducer Details DB01234 Dexamethasone approved, investigational, vet_approved unknown inducer Details DB01045 Rifampicin approved unknown inducer Details DB00624 Testosterone approved, investigational unknown substrate Details DB09048 Netupitant approved, investigational no substrate Details DB09102 Daclatasvir approved, investigational unknown substrate Details DB09054 Idelalisib approved no substrateinhibitor Details DB06412 Oxymetholone approved, illicit unknown inhibitor Details DB06595 Midostaurin approved, investigational unknown inducer Details DB11574 Elbasvir approved unknown substrate Details DB12332 Rucaparib approved, investigational no inhibitor Details DB13943 Testosterone cypionate approved unknown substrate Details DB13944 Testosterone enanthate approved unknown substrate Details DB13946 Testosterone undecanoate approved, investigational unknown substrate Details DB14649 Dexamethasone acetate approved, investigational, vet_approved unknown inducer Details DB00176 Fluvoxamine approved, investigational unknown inhibitor Details DB00599 Thiopental approved, vet_approved unknown substrate Details DB08930 Dolutegravir approved no substrate Details DB06595 Midostaurin approved, investigational unknown substrateinhibitorinducer Details DB13174 Rhein experimental unknown inhibitor Details DB11994 Diacerein approved, investigational unknown inhibitor Details DB11605 Myrrh approved unknown inducer Details DB11691 Naldemedine approved, investigational no substrate Details DB13878 Pibrentasvir approved, investigational unknown inhibitor Details DB13879 Glecaprevir approved, investigational unknown substrateinhibitor Details DB09205 Moxisylyte approved, investigational no substrate Details DB09568 Omega-3-carboxylic acids approved, investigational no substrate Details DB01601 Lopinavir approved no inhibitor Details DB01149 Nefazodone approved, withdrawn no inhibitor Details DB13141 Ambroxol acefyllinate experimental, investigational no substrate Details DB11792 Mirodenafil investigational unknown substrate Details DB11979 Elagolix approved, investigational no substrate Details DB08865 Crizotinib approved, investigational unknown substrateinhibitor Details DB11703 Acalabrutinib approved, investigational unknown substrate Details DB12267 Brigatinib approved, investigational unknown inducer Details DB12307 Foretinib investigational unknown substrate Details DB12130 Lorlatinib approved, investigational unknown substrateinhibitor Details DB00780 Phenelzine approved unknown inhibitor Details DB00593 Ethosuximide approved unknown substrate Details DB01201 Rifapentine approved, investigational unknown inducer Details DB00643 Mebendazole approved, vet_approved unknown substrate Details DB11757 Istradefylline approved, investigational unknown inhibitor Details DB00334 Olanzapine approved, investigational unknown inhibitor Details DB09212 Loxoprofen approved unknown substrate Details DB00635 Prednisone approved, vet_approved unknown inducer Details DB01222 Budesonide approved unknown substrateinducer Details DB00959 Methylprednisolone approved, vet_approved unknown substrateinducer Details DB11951 Lemborexant approved, investigational unknown inhibitorinducer Details DB12887 Tazemetostat approved, investigational unknown substrate Details DB14631 Prednisolone phosphate approved, vet_approved unknown inducer Details DB11652 Tucatinib approved, investigational unknown substrate Details DB15035 Zanubrutinib approved, investigational unknown substrate Details DB15685 Selpercatinib approved, investigational unknown inhibitor Details DB00409 Remoxipride approved, withdrawn unknown inhibitor Details DB15305 Risdiplam approved, investigational unknown inhibitor Details DB06448 Lonafarnib approved, investigational no substrateinhibitor Details DB11853 Relugolix approved, investigational unknown substrateinducer Details DB01586 Ursodeoxycholic acid approved, investigational unknown inducer Details DB11742 Ebastine approved, investigational unknown substrate Details DB15569 Sotorasib approved, investigational unknown substrate Details DB04216 Quercetin experimental, investigational no inhibitor Details DB00647 Dextropropoxyphene approved, illicit, investigational, withdrawn unknown inhibitor Details DB00333 Methadone approved no inhibitor Details DB01167 Itraconazole approved, investigational no inhibitor Details DB16536 Birch bark extract approved, experimental unknown inhibitor Details DB12070 Letermovir approved, investigational no substrateinhibitor Details